Find clinical trials for COVID-19 in Ann Arbor, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections

Coronavirus Infections

Human Influenza

Communicable Diseases

Pneumonia

Post-Acute COVID-19 Syndrome

Respiratory Distress Syndrome

COVID-19 trials near Ann Arbor, MI, USA:

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...

Enrolling

COVID-19

Biological: CVXGA (CVXGA50)

Biological: COMIRNATY®

Phase 2

•

Cyanvac

Southfield, Michigan, United States and 54 other locations

A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER)

study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID...

Enrolling

Covid19

Corona Virus Infection

Drug: Baricitinib

Phase 3

•

Lilly

Detroit, Michigan, United States and 19 other locations

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting

COVID-19

Biological: mRNA-1283.222

Biological: mRNA-1273.815

Phase 3

•

Moderna

Southfield, Michigan, United States and 217 other locations

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...

Enrolling

COVID-19

Drug: nirmatrelvir

Drug: ritonavir

Phase 1

•

Pfizer

Farmington Hills, Michigan, United States of America and 32 other locations

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...

Enrolling

COVID-19 SARS-CoV-2 Infection

Drug: placebo

Drug: ibuzatrelvir

Phase 3

•

Pfizer

Dearborn, Michigan, United States and 51 other locations

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling

COVID-19

Parainfluenza

Drug: DAS181 COVID-19

Drug: DAS181

Phase 3

•

Ansun Biopharma

Ann Arbor, Michigan, United States and 66 other locations

Locations recently updated

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) (MOVe-NOW)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling

Coronavirus Disease (COVID-19)

Drug: Placebo

Drug: Molnupiravir

Phase 3

•

Merck Sharp & Dohme (MSD)

Farmington Hills, Michigan, United States of America and 109 other locations

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling

COVID-19

Drug: nirmatrelvir

Drug: ritonavir

Phase 2, Phase 3

•

Pfizer

Detroit, Michigan, United States and 109 other locations

Status recently updated